DUBLIN: Scientists have developed a new gene therapy approach that treats an eye disease that leads to a progressive loss of vision.
This therapy treats dominant optic atrophy (DOA), a disease that causes degeneration of the optic nerves. DOA affects thousands of people across the globe.
So far, there is no cure for DOA, and the symptoms include moderate vision loss, some colour vision defects, and these symptoms can worsen over time and some people may become blind.
Clinical teams in the Royal Victoria Eye and Ear Hospital and the Mater Hospital collaborated with scientists from Trinity College, Dublin, to find a solution.
Scientists published their results in the journal Frontiers in Neuroscience.